Scholar

Ellen Meara

Ellen Rose Meara is a professor at The Dartmouth Institute for Health Policy and Clinical Practice, part of Dartmouth College… more

H-index: 41
Public Health 40%
Economics 30%

Reposted by Ellen Meara

jimflynn9.bsky.social
I had the great privilege of interviewing @johncawley.bsky.social for the ASHEcon newsletter. Check out our discussion and several other great interviews in the fall edition of the newsletter!

www.ashecon.org/category/new...
adrianna.bsky.social
Ben Sommers and I have a new piece up at @jamahealthforum.com on how to think about generalizing lessons from unwinding to looming new Medicaid red tape requirements.

jamanetwork.com/journals/jam...

We appreciate support from the @commonwealthfund.org for this work!

Reposted by Ellen Meara

academyhealth.bsky.social
A new study from researchers at UNC found that only 32.7% of substance use disorder treatment facilities offered perinatal programs. Learn more about their findings here: buff.ly/RDZcx4U
ermeara.bsky.social
Pragya Kakani giving a great talk on integration of oncologists at #IHEA2025.
Woman standing in front of graph of upward sloping lines.
ermeara.bsky.social
When plans for the car ferry fall through, try plan B… Now safely in Bali for #IHEA2025.
ermeara.bsky.social
So excited to see Carolyn San Soucie present on health care utilization around age 19 Medicaid redetermination at @ashecon.bsky.social
ermeara.bsky.social
Congratulations, Jose! This is well deserved.
dusetzinas.bsky.social
Excited to share new work in @jama.com on launch prices for cancer drugs in Medicare Part D. Prices are going up, but no trend change post-IRA. Mean monthly launch prices increased from $10,954 in 2012-2014 to $27,891 in 2023-2025. Many thanks to @arnoldventures.bsky.social for funding this work!
Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare
This study examines trends in launch prices and price increases for anticancer therapies covered under Medicare Part D and approved from 2010 to 2024.
jamanetwork.com
jama.com
Veterans in Medicare Advantage and Traditional Medicare used dental and vision services at similar rates, with no significant difference in total spending. #SGIM25

https://ja.ma/3ZficKj
Table 1. Characteristics of Veterans With Medicare Advantage
vs Traditional Medicare, 2018-2021
ermeara.bsky.social
One final note for @gregsargent.bsky.social and others asking, this evidence, on policies that save or cost lives for people living in every state, is at risk with cuts to federal research funds.
ermeara.bsky.social
3. Small choices, like the choice to let dual Medicare-Medicaid beneficiaries keep the LIS for some months after Medicaid loss, save many lives.
ermeara.bsky.social
2. Disruptions in insurance coverage have many harms. Yet, our patchwork health insurance is full of such “unforced errors”. Gaps in coverage rise after reaching key age, income, or other eligibility cutoffs, or because people struggle to show they are still eligible.
ermeara.bsky.social
There are many lessons. 1. Lower drug costs save lives. Efforts to lower drug costs to patients while supporting high-value innovation are needed.
ermeara.bsky.social
17 months after losing Medicaid, deaths were 3 per 1000 HIGHER in the group losing the LIS sooner. Note that these people still had Medicare coverage.
Image show two lines tracing percent of people surviving (y-axis) by months since Medicaid disenrollment (x-axis). Starting at 6 months through 24 months, the line for Early Medicaid disenrollment is lower.
ermeara.bsky.social
Depending on the month they leave Medicaid, some lose the LIS “early” within 6-12 months and some lose LIS “late”, 12-18 months later.
ermeara.bsky.social
Eric Roberts of @pennmedicine.bsky.social and @joefigs.bsky.social of @hsph.harvard.edu led this clever and careful study of dual Medicare-Medicaid beneficiaries. Each year 7-8% of these folks lose Medicaid & with it, help with drug costs, the low income subsidy (LIS).
ermeara.bsky.social
I’d say that 1. VBC has a role, not that it is “the” driver 2. 1 reason it’s hard to measure effect is that comparison groups have lots of VBC too and 3. The effect has more to do with direction of systems away from (v. Toward) FFS (that is the zeitgeist).
ermeara.bsky.social
This interview and spending a day asking AI to “teach me” about a policy topic have me equally terrified + impressed. After AI gave clear bulleted answers to my questions and it ranked answers in importance, it offered to give me a playbook to persuade…
joefigs.bsky.social
New @nejm.org study with alarming results.

The wealthiest Americans do not live as long as the wealthiest in other countries.

In fact, mortality among the wealthiest Americans appeared to be similar to people in the poorest quartile in northern and western
Europe.

www.nejm.org/doi/full/10....
ermeara.bsky.social
Why is she under the table? Is she getting news alerts too?

References

Fields & subjects

Updated 1m